title: [The combined chemotherapy with platinum of patients with inoperable non-small cell lung cancer].
abstract: Combination chemotherapy with cyclophosphamide, 5-fluorouracil, adriamycin and platinum was performed in 122 patients with stage III-IV squamous-cell cancer and adenocarcinoma of the lung. Control group included 84 cases of non-small-cell lung cancer treated with the same drugs except platinum. Ten patients with stage III disease received platinum-based combination chemotherapy and split-course radiotherapy in the total dose of 65-70 Gy. Complete or partial remission was obtained in 48.6 +/- 11.74% of stage III patients following three cycles of chemotherapy, with mean survival reaching 8.6 +/- 3.2 months. Survival in responders was 10.6 +/- 2.1 months. Chemoradiation treatment was associated with even higher survival (14.6 +/- 2.16 months). It is concluded that platinum be used in combination chemotherapy and chemoradiation treatment of the above categories of patients.
authors.forename: I V
authors.initials: IV
authors.lastname: Kas'ianenko
authors.forename: L A
authors.initials: LA
authors.lastname: Asliaev
authors.forename: B T
authors.initials: BT
authors.lastname: Bilynskiĭ
authors.forename: S A
authors.initials: SA
authors.lastname: Geshelin
authors.forename: I A
authors.initials: IA
authors.lastname: Golotiuk
authors.forename: S I
authors.initials: SI
authors.lastname: Golotiuk
authors.forename: E S
authors.initials: ES
authors.lastname: Gritsiak
authors.forename: S V
authors.initials: SV
authors.lastname: Zhero
authors.forename: O G
authors.initials: OG
authors.lastname: Koĭfman
authors.forename: E P
authors.initials: EP
authors.lastname: Sidorik
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011879:Radiotherapy Dosage; D012074:Remission Induction; D014455:Ukraine
chemical_list: D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin; D005472:Fluorouracil
vernacular_title: Kombinirovannaia khimioterapiia s paltinom neoperabel'nykh bol'nykh nemelkokletochnym rakom legkogo.